Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production

FEMS Microbiology Letters

Volumn 173, Issue 2, 1999, Pages 459-465

  Caroff, N ^a   Espaze, E ^b   Berard I ^b   Richet, H ^b   Reynaud, A ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b HÔTEL DIEU   (France)

Author keywords

Cephalosporinase; Escherichia coli; Mutation; Promoter

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CLAVULANIC ACID; PENICILLIN DERIVATIVE; TICARCILLIN; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONSENSUS SEQUENCE; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; CEFOXITIN; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CEPHAMYCINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA;

ESCHERICHIA COLI;

EID: 0032970769     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(99)00111-1     Document Type: Article

References (16)

1. Livermore, D.M. (1995) β-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8, 557-584.
2. Jaurin, B., Grundström, T., Edlund, T., Normark, S. (1981) The E. coli β-lactamase attenuator mediates growth rate-dependent regulation. Nature 290, 221-225.
3. Edlund, T., Grundström, T., Normark, S. (1979) Isolation and characterization of DNA repetitions carrying the chromosomal β-lactamase gene of Escherichia coli K12. Mol. Gen. Genet. 173, 115-125.
4. Olsson, O., Bergström, S., Normark, S. (1982) Identification of a novel ampC β-lactamase promoter in a clinical isolate of Escherichia coli. EMBO J. 1, 1411-1416.
5. Olsson, O., Bergström, S., Lindberg, F.P., Normark, S. (1983) ampC β-lactamase hyperproduction in Escherichia coli: Natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella. Proc. Natl. Acad. Sci. USA 80, 7556-7560.
6. Matthew, M., Harris, A.M., Marshall, M.J., Ross, G.W. (1975) The use of analytical isoelectric focusing for detection and identification of β-lactamase. J. Gen. Microbiol. 88, 169-178.
7. Labia, R., Barthelemy, M. (1979) L'enzymogramme des β-lactamases: adaptation en gel de la méthode iodométrique. Ann. Microbiol. 130B, 295-304.
8. Caroff, N., Lepelletier, D., Orsonneau, J.-L., Blin, A., Labia, R., Richet, H., Reynaud, A. (1999) Bacterial and epidemiologic study of the resistance to oxyiminocephalosporins in Escherichia coli in a French hospital. Clin. Microb. Infect. 5, 37-46.
9. Jaurin, B. and Grundström, T. (1981) ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type. Proc. Natl. Acad. Sci. USA 78, 4897-4901.
10. Fournier, B., Lagrange, P.H., Philippon, A. (1996) β-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrob. Agents Chemother. 40, 460-463.
11. Conejo, M.C., Martinez-Martinez, L., Pascual, A., Ballesta, S., Hernandez-Alles, S., Benedi, V.J., Perea, E.J. (1997) Activity of cefepime (PIM) and four other cephalosporins against clonally-related strains of Escherichia coli hyperproducing chromosomal β-lactamase and with altered-porin profiles (Abstract C-198). In: Program and Abstracts of the 37th International Conference of Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Toronto, Ont., Canada.
12. Haliassos, A., Chomel, J.C., Tesson, L., Baudis, M., Kruh, J., Kaplan, J.C., Kitzis, A. (1989) Modification of enzymatically amplified DNA for the detection of point mutation. Nucleic Acids Res. 17, 3606.
13. Pina, M., Occhialini, A., Monteiro, L., Doermann, H.-P., Mégraud, F. (1998) Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J. Clin. Microb. 36, 3285-3290.
14. Kobayashi, M., Nagata, K., Ishihama, A. (1990) Promoter selectivity of Escherichia coli RNA polymerase: effect of base substitutions in the promoter -35 region on promoter strength. Nucleic Acids Res. 18, 7367-7372.
15. Levesque, C., Brassard, S., Lapointe, J., Roy, P.H. (1994) Diversity and relative strength of tandem promoters for the antibiotic-resistance genes of several integrons. Gene 142, 49-54.
16. Jaurin, B., Grundström, T. and Normark, S. (1982) Sequence elements determining ampC promoter strength in E. coli. EMBO J. 1, 875-881.